SCHEMBL16997484

SCHEMBL16997484

O=C1c2ccccc2C(=O)N1CCOS(=O)(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.54
MAPT P10636 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
RAB9A P51151 7/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
NPSR1 Q6W5P4 2/20 0.49
NPC1 O15118 3/20 0.49
CASP3 P42574 2/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
TSHR P16473 2/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA9 Q16790 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694647 0.89 HPGD (0.60) HPGDMAPTKMT2AALDH1A1KDM4E
SCHEMBL30225654 0.89 HPGD (0.60) HPGDMAPTKMT2AALDH1A1KDM4E
SCHEMBL26813893 0.82 HPGD (0.55) HPGDMAPTKMT2AALDH1A1KDM4E
SCHEMBL1275770 0.82 HPGD (0.55) HPGDMAPTKMT2AALDH1A1KDM4E
SCHEMBL27033132 0.82 HPGD (0.55) HPGDMAPTKMT2AALDH1A1KDM4E
SCHEMBL25436703 0.82 HPGD (0.55) HPGDMAPTKMT2AALDH1A1KDM4E
SCHEMBL10770035 0.81 VDR (0.55) HPGDMAPTKMT2AALDH1A1RAB9A
SCHEMBL14015387 0.80 SMN1; SMN2 (0.54) HPGDMAPTKMT2AALDH1A1RAB9A
SCHEMBL6716400 0.80 HPGD (0.55) HPGDMAPTKMT2AALDH1A1RAB9A
SCHEMBL290900 0.79 RAB9A (0.50) HPGDMAPTKMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160332977-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. 2016-11-17 US disclosed
US-20160332976-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. 2016-11-17 US disclosed
US-20160332977-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. 2016-11-17 US disclosed
US-20160332976-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. 2016-11-17 US disclosed
WO-2015123519-A2 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. (US) 2015-08-20 WO disclosed
US-20150225384-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. 2015-08-13 US disclosed
US-20150225384-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS GILEAD SCIENCES, INC. 2015-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160332976-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS KCNN2, KCNJ2, KCNN1 HPGD 1696/4885MAPT 3607/4885KMT2A 2781/4885
US-20160332977-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS KCNN2, KCNJ2, KCNN1 HPGD 1696/4885MAPT 3607/4885KMT2A 2781/4885
US-20150225384-A1 PROCESSES FOR PREPARING FUSED HETEROCYCLIC ION CHANNEL MODULATORS KCNN2, KCNJ2, KCNN1 HPGD 1696/4885MAPT 3607/4885KMT2A 2781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.